The dysphagia market holds significant importance as it addresses a prevalent and often overlooked medical condition involving difficulty in swallowing. With an aging global population and an increase in related conditions such as stroke and neurological disorders, the demand for dysphagia management solutions is rising. As healthcare systems focus on improving patient outcomes and reducing healthcare costs, the dysphagia market plays a crucial role in meeting these goals by providing effective solutions for a condition that can lead to serious complications if left untreated.
According to Data Bridge Market Research analyses the Global Dysphagia Market was valued at USD 3.05 billion in 2021 and is expected to reach USD 4.62 billion by 2029, registering a CAGR of 5.30% during the forecast period of 2022 to 2029.
"Rise in smoking addiction boosts the market growth"
The growing addiction to smoking is projected to drive the dysphagia market's expansion due to the link between prolonged cigarette use and swallowing difficulties. Smoking, a major contributor to oropharyngeal cancer, is identified as a significant cause of dysphagia. As tobacco-related health issues continue to claim millions of lives annually, the rising prevalence of oropharyngeal cancer is expected to fuel demand for dysphagia-related healthcare services and treatments. This connection establishes smoking addiction as a key driver for the dysphagia market.
What restraints the growth of the global dysphagia market?
“Complexity associated with diagnosis process hampers the market growth”
The dysphagia market faces growth challenges due to the complexity of accurately diagnosing its underlying causes. Dysphagia, difficulty in swallowing, stems from diverse factors such as neurological disorders and structural abnormalities. Diagnosing the exact cause is complicated by varied symptoms, multifactorial origins, and the role of dysphagia as a symptom of other conditions. The interpretative challenges of diagnostic tests and patient variability add further complexity.
Segmentation: Global Dysphagia Market
The global dysphagia market is segmented on the basis of type, treatment type, route of administration, diagnosis, end-user, and distribution channel.
- On the basis of type, the global dysphagia market is segmented into esophageal dysphagia, oral dysphagia, and pharyngeal dysphagia
- On the basis of treatment type, the global dysphagia market is segmented into medicines, and surgery
- On the basis of route of administration, the global dysphagia market is segmented into oral, parenteral, and others
- On the basis of diagnosis, the global dysphagia market is segmented into manometry, endoscopy, barium swallow test, swallow study, and others
- On the basis of end-user, the global dysphagia market is segmented into hospitals, specialty clinics, homecare, and others
- On the basis of distribution channel, the global dysphagia market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others
Regional Insights: North America dominates the Global Dysphagia Market
North America dominates the dysphagia market due to a well-established healthcare system, a high prevalence of dysphagia, and significant investments by key players in advanced technologies. The region's leadership is driven by its robust infrastructure, addressing the rising incidence of swallowing difficulties, and a strategic focus on innovative solutions, positioning North America at the forefront of global dysphagia care.
Asia-Pacific's dysphagia market is set to grow significantly due to an increasing number of generic manufacturers, ensuring cost-effective solutions, and rising healthcare expenditure, signaling improved accessibility and support for individuals with swallowing difficulties in the region.
To know more about the study visit https://www.databridgemarketresearch.com/jp/reports/global-dysphagia-market
Recent Developments in the Global Dysphagia Market
- In September 2020, Thick-It Brand unveiled an innovative variety pack of dysphagia nutrition products, including Purée Protein, Purée Vegetable, and Ready-to-Drink options. The ready-to-drink alternatives come in IDDSI Level 2 – Mildly Thick (nectar) and IDDSI Level 3 – Moderately Thick (honey) consistencies, showcasing the upgraded Thick-It Clear Advantage drinks. Purées, available in IDDSI Level 4 – Puree, complete the comprehensive range, catering to diverse swallowing needs
The Prominent Key Players Operating in the Global Dysphagia Market Include:
- Dr. Reddy's Laboratories Ltd. (India)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Dr. Reddy's Laboratories Ltd. (India)
- Cipla Inc. (U.S.)
- Zydus Cadila (India)
- WOCKHARDT (India)
- Lannett (U.S.)
- Cook (U.S.)
- Fresenius Kabi AG (Germany)
- BD (U.S.), Eisai Co., Ltd. (Japan)
Above are the key players covered in the report, to know about more and exhaustive list of global dysphagia market companies contact, https://www.databridgemarketresearch.com/jp/contact
Research Methodology: Global Dysphagia Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
